ClinicalTrials.Veeva

Menu

Efficacy of Two Nasal Products for Decongestion and Mucus Fluidification (DEFI)

Y

YSLab

Status

Completed

Conditions

Rhinitis

Treatments

Other: Sea water solution

Study type

Interventional

Funder types

Industry

Identifiers

NCT04230993
2019-A01705-52

Details and patient eligibility

About

The main objective is to compare the effect of nasal washing on nasal discharge and nasal congestion during treatment after 3 days of use.

Full description

The main endpoint is a symptom score derived from the Jackson scale: sum of 2 items relating to runny nose and nasal congestion (stuffy nose), with ratings of 0 to 3 for each (0: absent ; 1: mild; 2: moderate; 3: severe).

Enrollment

210 patients

Sex

All

Ages

3+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Person with an upper respiratory condition (cold, rhinitis, nasopharyngitis ...) with symptoms of nasal congestion and intense runny nose moderate to severe (Jackson derived score ≥ 4)
  • Ability of the patient (for adults) or their legal representative (for children) to follow the guidelines of the medical device
  • have given their written informed consent

Exclusion criteria

  • Patient with no cold symptoms, including no nasal congestion (chronic dry rhinitis...)
  • Patient under treatment with cortisone derivative, mucolytic, or medication containing pseudoephedrine or related product acting on nasal congestion or having used such a product in the 3 days before inclusion
  • Patient who used a nasal wash product in the 3 days before inclusion
  • Patient allergic to seafood, or to any of the components of the products under study
  • Vulnerable patient whose inclusion is not justified by the research objectives: woman pregnant, parturient, psychiatric patient, or adult subject to legal protection
  • Patient participating or having participated in any other clinical study in the 30 days before the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

210 participants in 3 patient groups

Ocean Bio Actif-Fluid+
Experimental group
Description:
Moderate hypertonic seawater solution (15 g / L NaCl) with polysorbate 80. The use is 1 to 2 sprays per nostril 4 times a day until symptoms of cold disappear, according to the instructions for use of the products.
Treatment:
Other: Sea water solution
Ocean Bio Active-Stuffy nose
Experimental group
Description:
Moderate hypertonic seawater solution (15 g / L NaCl) without polysorbate 80. The use is 1 to 2 sprays per nostril 4 times a day until symptoms of cold disappear, according to the instructions for use of the products.
Treatment:
Other: Sea water solution
Ocean Bio Active-Hygiene of the nose
Active Comparator group
Description:
Isotonic seawater solution (9 g / L NaCl). The use is 1 to 2 sprays per nostril 4 times a day until symptoms of cold disappear, according to the instructions for use of the products.
Treatment:
Other: Sea water solution

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems